Ledger.Open graph →

SEC Form D · filed August 17, 2016

Cleave Biosciences, Inc

Offering

$36.8M

Sold

$26.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

BURLINGAME, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Timothy Smith · Burnaby, British Columbia, CanadaExec Alfred Scheidegger · Burlingame, CADirector Mark Rolfe · Burlingame, CAExec Peter Thompson · Seattle, WADirector Laura Shawver · San Diego, CAExec · Director Lewis Shuster · Vancouber, British Columbia, CanadaDirector Carol Gallagher · San Diego, CADirector Jonathan Root · Maple Grove, MNDirector Andrew Schwab · Menlo Park, CADirector Dennis Henner · San Diego, CADirector Alfred Scheidegger · Burlingame, CADirector Mark Rolfe · Burlingame, CAExec Peter Thompson · New York, NYDirector Laura Shawver · Burlingame, CAExec · Director Lewis Shuster · Tucson, AZDirector Carol Gallagher · San Diego, CADirector Jonathan Root · San Francisco, CADirector Timothy Smith · Durham, NCExec Andrew Schwab · Pleasanton, CADirector Dennis Henner · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗